Public Reaction, Hesitancy, and Global Context

China has made a major update to its National Immunization Program (NIP) by including a domestically produced HPV vaccine, offering it free to school-aged girls. This first revision in 17 years is a significant public health advancement, driven by a growing national focus on preventive care and rising cancer awareness. By providing widespread, free access, the policy directly tackles barriers of cost and availability, promising to drastically reduce cervical cancer rates and protect the long-term health of millions of women. On the show: Steve, Niu Honglin & Yushan